Abbott expects to start shipping EleCare infant formula in coming weeks
The company had shut down the plant in February and recalled its infant formula, including Similac and EleCare, after reports of bacterial infections in babies who had consumed products made at the facility
Abbott Laboratories said recently it expects to begin releasing EleCare formula in the coming weeks from its recently reopened Sturgis plant, which has been at the centre of a baby formula shortage in the US.
The company had shut down the plant in February and recalled its infant formula, including Similac and EleCare, after reports of bacterial infections in babies who had consumed products made at the facility.
Abbott briefly reopened this plant early last month, but had to shut it down after about two weeks due to thunderstorms and heavy rains.
The company is initially manufacturing EleCare and is working to restart the production of Similac.
EleCare formula is meant for children and babies who cannot tolerate intact protein or may have protein allergies.
Abbott said it is also extending the rebates offered on its products until 30th September, in states where the company holds the contract when Similac is unavailable.
Edits by EP News Bureau
- Advertisement -